Branded Generics News Today

/PRNewswire/ -- The global ursodeoxycholic acid market size is estimated to grow by USD 358.41 million from 2023-2027, according to Technavio. The market is...

The Global Branded Generics Industry is on the cusp of remarkable growth, with a projected value of US$ 327.8 million in 2023. Projections reveal an impressive growth trajectory, soaring to US$ 747.2 million by 2033, bolstered by a noteworthy Compound Annual Growth Rate (CAGR) of 8.6%.This upsurge can be attributed...

Dublin, July 14, 2023 (GLOBE NEWSWIRE) -- The "Branded Generics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. ...

/PRNewswire/ -- The "United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company Analysis" report...

The management is confident to scale up margins again in the coming years on the back of enhanced contribution from Branded Generics business and normalisation of freight costs

Dublin, May 10, 2023 (GLOBE NEWSWIRE) -- The "United States Generic Drugs Market, Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of...

Expected revenue, operating profit margin growth to bolster the health of industry players

For investors in hospital stocks, Khemka says the right time for entry is when the company has completed its capex, because the downside potential from that level is less, while the upside is good.

Adani Ports & Special Economic Zone (APSE) Q2 profit overshot the consensus estimate by 40%, mainly due to a change in accounting approach, said Nuvama Institutional Equities

The "Europe Branded Generics Market Forecast to 2028 COVID-19 Impact and Regional Analysis by Therapeutic Application, Distribution Channel, Drug Class, and Formulation Type" report has been added to